Bovine respiratory disease is a multifactorial and complex disorder caused due to a combination of more than one microbial pathogens, inadequate housing conditions, impaired host immunity, and environmental factors.
Technavio’s analysts forecast the global bovine respiratory disease treatment to grow at a CAGR of 8.11% during the period 2017-2021.
Covered in this report The report covers the present scenario and the growth prospects of the global bovine respiratory disease treatment for 2017-2021. To calculate the market size, the report considers the include sales of branded drugs, generic drugs, and vaccines.
The market is divided into the following segments based on geography: - Americas - APAC - EMEA
Technavio's report, Global Bovine Respiratory Disease Treatment 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Other prominent vendors - Bimeda Group - Ceva - Huvepharma - Inovio Pharmaceuticals - Med-Pharmex - Norbrook Laboratories - Plumbline Life Sciences
Market driver - Development of novel products - For a full, detailed list, view our report
Market challenge - High cost of therapies coupled with presence of natural alternatives - For a full, detailed list, view our report
Market trend - Growing focus on the development of combination drugs - For a full, detailed list, view our report
Key questions answered in this report - What will the market size be in 2021 and what will the growth rate be? - What are the key market trends? - What is driving this market? - What are the challenges to market growth? - Who are the key vendors in this market space? - What are the market opportunities and threats faced by the key vendors? - What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Methodology Research methodology is based on extensive primary and secondary research. Primary research includes in-depth interviews with industry experts, vendors, resellers and customers. Secondary research includes Technavio Platform, industry publications, company reports, news articles, analyst reports, trade associations and the data published by Government agencies.
Our reports have been used by over 10K customers, including:
Immuno-oncology is a unique approach that uses the body’s immune system to fight cancer. These therapies activate an individual’s immune system, making it able to recognize cancer cells and destroy them. Immuno-oncology therapies provide long lasting anti-cancer benefits to patients who previously had very few treatment...
Hypoglycemia Disease - Global Clinical Trials Review, H2, 2020 Summary clinical trial report, “Hypoglycemia Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Hypoglycemia Clinical trials scenario.This report provides top line data relating to the clinical trials on Hypoglycemia. Report...
200 pages •
By The Business Research Company
• Sep 2020
Major players in the benign prostatic hyperplasia (BPH) treatment devices and equipment market are Karl Storz, Lumenis, Olympus, Urologix and Boston scientific Inc. The global benign prostatic hyperplasia (bph) treatment devices and equipment market is expected to decline from $4.5 billion in 2019 to $4.1 billion in 2020 at a compound...
RNA Interference Technology Market Research Report by Therapeutics (Autoimmune Hepatitis, Hepatitis B and C, Neurological Disorders, and Oncology) - Global Forecast to 2025 - Cumulative Impact of COVID-19 The Global RNA Interference Technology Market is expected to grow from USD 15,273.86 Million in 2019 to USD 42,005.88...
Travel Vaccines Market Research Report by Composite (Combination Vaccines and Mono Vaccine), by Type (Attenuated Vaccines, Conjugate Vaccines, DNA Vaccines, Inactive Vaccines, and Recombinant Vector Vaccines) - Global Forecast to 2025 - Cumulative Impact of COVID-19 The Global Travel Vaccines Market is expected to grow...
Liver Diseases Therapeutics Market Research Report by Treatment (Anti Viral Drugs, Chemotherapy Drugs, Corticosteroids, Immunoglobulin, and Immunosuppressant Drugs), by End User (Ambulatory Surgery Centers and Hospitals) - Global Forecast to 2025 - Cumulative Impact of COVID-19 The Global Liver Diseases Therapeutics...
The global orphan drugs market exhibited moderate growth during 2014-2019. Orphan drugs refer to pharmaceutical products used for the diagnosis, prevention and treatment of rare medical disorders. These drugs are manufactured to meet a specific public health requirement and usually have a limited market as they are...
The global hospital infection therapeutics market grew at a CAGR of around 5% during 2014-2019. Hospital infection therapeutics refers to various pharmaceutical drugs used for the treatment of nosocomial infections. These infections can be acquired at hospitals, nursing homes, rehabilitation facilities and other clinical...
133 pages •
By Global Industry Analysts
• Sep 2020
Global Pneumonia Therapeutics Market to Reach US$22.5 Billion by the Year 2027 Amid the COVID-19 crisis, the global market for Pneumonia Therapeutics estimated at US$14.5 Billion in the year 2020, is projected to reach a revised size of US$22.5 Billion by 2027, growing at a CAGR of 6.5% over the analysis period 2020-2027.Drugs, one...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.